MedTrace Logo

Effects of Methylprednisolone After Total Hip Arthroplasty

NCT00968903 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2011-09-29

No results posted yet for this study

Summary

The purpose of the study is to compare the effects of pre-operative methylprednisolone (125mg iv) versus placebo on postoperative outcome after hip arthroplasty.

The hypothesis is that pre-operative methylprednisolone (125mg iv) will reduce time to fulfill discharge criteria.

Conditions

  • LOS
  • Postoperative Pain
  • Postoperative Nausea and Vomiting
  • Sleeping Quality
  • Fatigue
  • Inflammatory Response

Interventions

DRUG

Methylprednisolone

Methylprednisolone 125 mg iv pre-operatively

Sponsors & Collaborators

  • Lundbeck Foundation

    collaborator OTHER

  • Hvidovre University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2011-01-31
Completion
2011-01-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00968903 on ClinicalTrials.gov